Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Studies on the clinical pharmacology and toxicology of isophosphamide (NSC-109724).

× No keyword cloud information.

13 in total

1. Basic principles in preclinical cancer chemotherapy.

Authors: N Brock; J Pohl; B Schneider
Journal: J Cancer Res Clin Oncol Date: 1990 Impact factor: 4.553

2. The pharmacokinetics of ifosfamide given as short and long intravenous infusions in cancer patients.

Authors: L D Lewis; D L Fitzgerald; P Mohan; N Thatcher; P G Harper; H J Rogers
Journal: Br J Clin Pharmacol Date: 1991-01 Impact factor: 4.335

Review 3. Antineoplastic drugs in 1990. A review (Part II).

Authors: D J Black; R B Livingston
Journal: Drugs Date: 1990-05 Impact factor: 9.546

4. Comparative study on human pharmacokinetics of activated ifosfamide and cyclophosphamide by a modified fluorometric test.

Authors: T Wagner; D Heydrich; T Jork; G Voelcker; H J Hohorst
Journal: J Cancer Res Clin Oncol Date: 1981 Impact factor: 4.553

5. Placebo-controlled double-blind comparative study on the preventive efficacy of mesna against ifosfamide-induced urinary disorders.

Authors: M Fukuoka; S Negoro; N Masuda; K Furuse; M Kawahara; N Kodama; H Ikegami; S Nakamura; H Nishio; T Ohnoshi
Journal: J Cancer Res Clin Oncol Date: 1991 Impact factor: 4.553

Review 6. Ifosfamide pharmacokinetics.

Authors: L D Lewis
Journal: Invest New Drugs Date: 1991-11 Impact factor: 3.850

Studies on the clinical pharmacology and toxicology of isophosphamide (NSC-109724).

1. Basic principles in preclinical cancer chemotherapy.

2. The pharmacokinetics of ifosfamide given as short and long intravenous infusions in cancer patients.

Review 3. Antineoplastic drugs in 1990. A review (Part II).

4. Comparative study on human pharmacokinetics of activated ifosfamide and cyclophosphamide by a modified fluorometric test.

5. Placebo-controlled double-blind comparative study on the preventive efficacy of mesna against ifosfamide-induced urinary disorders.

Review 6. Ifosfamide pharmacokinetics.

7. VP 16 plus ifosfamide plus cisplatin as salvage therapy in refractory testicular cancer.

8. Bioavailability of ifosfamide in patients with bronchial carcinoma.

9. Mesnum as a protector against kidney and bladder toxicity with high-dose ifosfamide treatment.

10. Toxicity and response to high-dose ifosfamide + mesna as salvage therapy for advanced breast cancer.